Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nguyendofx
    Member
    • May 2011
    • 31

    #1

    ChIP-Seq / Peaks Caller

    Hello All,

    There are many ChIP-Seq Peak detection applications available (open source and commercial). I don't know which one better than other AND when to select a right one?

    The short list: MACS, QuEST, SISSRS, HOMER, ERANGE.

    Which one is good for peaks finding (E.g Transcription Factor binding, histone, polymerases ..etc)

    Thanks,
    Ng
    Last edited by nguyendofx; 05-07-2012, 10:53 PM.
  • mudshark
    Senior Member
    • Jan 2009
    • 138

    #2
    As far as I know there has not been ANY objective comparison of Peak callers on a sufficient number of non-virtual reference data sets (having different read depths, different binding modes, different genome sizes, different mappability fractions..) to estimate their performance. There are some papers out, however..

    furthermore, it might be of interest if the peak caller is actually able to make a two-sample analysis (ip versus control) and if it can operate on replicate samples.

    if you are interested in my experience - for sure not universally valid - but tested on quite a lot of complementary data with different sequencing depth:
    QuEST > SISSSR > Cisgenome2 > MACS in terms of specificity
    SISSR > MACS > Cisgenome2 > QuEST in terms of sensitivity

    unfortunately Quest and SISSR cannot deal with replicates, MACS?..

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 02:55 AM
    0 responses
    5 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Working...